Hot Deals:
amol minechem 601.00 (0.17 %) anglo french drugs 930.00 (3.33 %) anugraha valve 280.00 (1.82 %) apl metals 40.00 (-2.44 %) apollo fashion 107.00 (1.90 %) archit nuwood 500.00 arkfin investments 50.00 arohan 202.00 (1.00 %) assam carbon 265.00 (1.92 %) avalokiteshvar 242.00 (0.83 %) axles india 610.00 (1.67 %) balmer lawrie 202.00 (1.00 %) bharat hotels 345.00 (1.47 %) bima mandi 235.00 (-2.08 %) bira 555.00 (-0.89 %) boat 1,380.00 (-1.43 %) c & s electric 840.00 (-1.18 %) cable corporation 13.00 (-0.76 %) capgemini 11,900.00 (0.85 %) care health 186.00 (-1.59 %) carrier aircon 545.00 (-0.91 %) cial 326.00 (0.31 %) csk 170.00 (-1.16 %) dalmia refract 260.00 (1.96 %) dfm foods 467.00 dsp merrill lynch 1,000.00 east india pharma 39.00 (-2.50 %) eaton fluid 440.00 (3.53 %) electronica plastic 2,100.00 (-0.99 %) elgi ultra 400.00 elofic 2,100.00 (2.44 %) esl steel 46.00 (1.10 %) fincare business 86.00 (3.61 %) fincare sfbl 205.00 (1.49 %) fino paytech 133.00 (-1.48 %) flipkart india 231,001.00 (0.00 %) frick india 15,600.00 (-0.95 %) gkn driveline 1,325.00 (-0.38 %) godavari bio 71.00 (1.43 %) goodluck defence 235.00 (2.17 %) group pharma 300.00 gynofem healthcare 63.00 (-3.08 %) hazira cargo terminals limited 205.00 (1.49 %) hdb financial 1,120.00 (-0.88 %) hdfc ergo 370.00 (1.70 %) hdfc securities 11,300.00 (-1.74 %) hella india 910.00 (1.11 %) hero fincorp 1,990.00 (-0.50 %) hexaware 720.00 (-2.70 %) hicks 1,450.00 (2.11 %) hira ferro 180.00 (2.86 %) honeywell electrical 6,200.00 (1.64 %) ikf finance 312.00 (0.65 %) incred financial 10.00 (1.01 %) incred holdings 165.00 (-1.79 %) india carbon 1,135.00 (-1.30 %) india exposition 121.00 (0.83 %) indian potash 3,250.00 (1.56 %) indian seamless 175.00 (2.94 %) indo alusys 25.75 (-0.96 %) indofil 1,030.00 (0.49 %) infinite computer 405.00 (1.25 %) inkel 29.00 (-3.33 %) jana small finance bank 75.00 kel 610.00 (-2.40 %) kial 126.00 (-1.56 %) klm axiva 15.75 (1.61 %) kurlon limited 1,255.00 (0.40 %) lava 49.00 (-2.00 %) mahindra rural mrhfl 100.00 manipal housing 74.00 (2.07 %) manjushree technopack 3,050.00 (0.66 %) martin & harris 975.00 (-1.52 %) matrix gas 950.00 (-1.04 %) merino 3,350.00 (1.52 %) minosha 282.00 (0.71 %) mitsubishi heavy 207.00 (-0.48 %) mkcl 410.00 (-2.38 %) mobikwik 595.00 (-0.34 %) mohan meakin 2,150.00 (2.38 %) mohfl 13.70 (-0.36 %) msei 1.16 (0.87 %) msil 36.00 (2.86 %) nayara energy 595.00 (-0.83 %) nayara energy ncd 315.00 (3.28 %) ncdex 220.00 (-0.90 %) ncl buildtek 310.00 (3.33 %) ncl holdings 92.00 (1.10 %) northern arc 400.00 nsdl 825.00 (1.85 %) nse 5,700.00 (1.79 %) orbis financial 340.00 (0.29 %) oswal minerals 60.10 (-1.48 %) otis 3,700.00 (-0.67 %) oyo 44.00 (-2.22 %) panasonic appliances 262.00 (0.77 %) paymate india 520.00 (-0.95 %) pharmeasy 8.70 (-1.14 %) pharmed limited 480.00 (2.13 %) philips domestic 720.00 (-1.37 %) philips india 910.00 (-1.09 %) pnb metlife 70.00 proyuga adtech 25.00 purity flexpack 20.00 ramaraju surgical 255.00 (-1.92 %) rapido 16,650.00 (0.03 %) rasoi 31,500.00 (0.32 %) reliance gic 505.00 (1.00 %) resins plastics 475.00 (3.26 %) ring plus aqua 530.00 (0.95 %) rrl 1,275.00 (2.00 %) rrp s4e innovation 345.00 (-1.43 %) sab miller 490.00 (2.94 %) sbi amc 2,150.00 (0.94 %) sbi general insurance 620.00 (3.33 %) scottish assam 480.00 (2.13 %) shriram life 261.00 (0.38 %) sigachi laboratories 36.00 (-2.70 %) signify 1,330.00 (-0.75 %) smile microfinance 55.00 (1.85 %) sterlite power 748.00 (-0.27 %) studds 915.00 (-1.08 %) svsml 315.00 (2.94 %) swiggy 355.00 (1.43 %) t stanes 810.00 (1.25 %) tata capital 1,040.00 (-0.95 %) teesta agro 77.00 (-6.21 %) trl krosaki 1,300.00 (1.96 %) urban tots 92.00 (2.22 %) utkarsh coreinvest 310.00 (3.33 %) vadilal dairy 10.00 vikram solar 285.00 (-1.72 %) vivriti capital 1,150.00 (-0.86 %) waree energies 2,150.00 (-0.46 %)
×

Wintac Share Price

Wintac Limited Fundamentals

Company Name
Wintac Limited
Scrip Name
WINTAC
Last Traded Price
207.00
+ 0.98 %
Sector
Pharma
PAN No.
AAACR8613H
Face Value
10
No. of Outstanding Shares
10,024,242
EPS
14.46
PE ratio
14.32
Market Capitalization
207.50 Crore
Book value
5.26
P/BV
39.35
ISIN No.
INE812C01016
Available on
nsdlcdsl
ROFR Require
No
52 Week High
52 Week Low
Lifetime High
207.00 (22/02/23)
Lifetime Low
5.00 (17/09/21)
Day High
207.00
Day Low
207.00

WINTAC Price Performance

Wintac Limited Delisted Share - Company Overview

WINTAC LIMITED was established as an offspring of Bangalore Pharmaceuticals and Research Laboratories Private Limited under the name of RECON LIMITED. In 2001, the name of the company was changed to Wintac Limited. The Company is engaged in the business of manufacturing goods and all its other activities revolve around this business. The company’s range of specialties includes Large and small-volume injectable and Ophthalmic solutions.

The delisting open offer for shares of WINTEC LIMITED was successful as per Regulation 17 of the Delisting Regulations at an exit price of `350 per share under the Reverse Book Building Process. The BSE vide its’ notice no. 20201211-16 dated December 11, 2020, communicated that the trading in the Equity Shares of the Company WINTEC LIMITED   (Scrip Code: 524758) will be discontinued from December 18, 2020, and the scrip will be delisted from Exchange records with effect from December 28, 2020. 

Wintac Limited provides outsourcing for sterile pharmaceutical products and Ophthalmic Solutions. Wintac Limited takes care of its customers from formulation development to commercial manufacturing.

The product range of the company includes a wide range of ophthalmic preparations and Injectables of Large and small volume parenteral.

The equity shares of the company have been delisted from the Bombay Stock Exchange of India on December 28, 2020.

Wintac Limited Incorporation Details

CIN of Wintac Limited

L85110KA1990PLC011166

Registration Date of Wintac Limited

23 August 1990

Category/Sub-category of Wintac Limited

Public Limited

Wintac Limited Registered office address and contact details

54/1, BOODHIHAL, NELAMANGALA,

BENGALURU - 562123.

PH:- 080-67086500

Wintac Limited Registrar and Transfer Agent address and contact details

CANBANK COMPUTER SERVICES LTD.,

NO.218, J.P.ROYALE, II MAIN, SAMPIGE ROAD,

MALLESWARAM, BANGALORE - 560003.

PH: 080-23469661/9662

Wintac Limited Principal Business Activities

Name and Description of main products/services

NIC Code of the product/service

% to the total turnover of the Company

Formulation Sales

99532693

80.65%

Manufacturing Charges

99532693

0.21%

Formulation Development

99839390

19.14%

Wintac Limited Board of Directors

Shri S.T.R. Mady (Chairman)

Shri S. Jayaprakash Mady (Director)

Shri R.A. Thirumoorti (Director)

Dr. K. Paranjothy (Director)

Ms. S. Nanthitha (Additional Director)

Mr. Arshad Kagalwalla (Additional Director)

Shri Sunil B. Gundewar (Manager & C.O.O)

Shri B.P. Thyagaraj V.P. (Finance) & Secretary

Particulars of Subsidiary and Associate Companies

Wintac Limited does not have any subsidiary or associate company.

Shareholding Pattern (As of 31-03-2020)

S. No.

Shareholders’ Name

Number of shares

% of total Shares of the company

1

VEEGO Pharma LLC (Promoter)

92,40,346

92.18%

2

Public Shareholding

7,83,896

7.82%

 

Total

1,00,24,242

100.00%

Industry Outlook

 Indian Pharmaceutical market ranks as 3rd largest in the world in terms of volume and 14th largest in terms of value. Healthcare has become one of the largest sectors of the Indian economy, in terms of both employment and revenue. India is known as the Pharmacy of the world and is the largest provider of generic drugs at a global level. The pharmaceutical industry of India supplies over 50% of the global demand for various vaccines, 40% of generic demands in the USA, and 25% of all the medicines in the United Kingdom. Excellent Research & Development, low cost of labor, availability of management and technical personnel, and local equipment availability has helped India to manufacture pharma products at a very low cost.

The Indian healthcare market may see a 3 fold jump in terms of value to reach US$ 372 billion by FY 2022. The growth can be attributed to rising income, greater health awareness, increased precedence of lifestyle disease, and Indian prominence in making medicinal products for the treatment of COVID 19. India aims to achieve vaccination for COVID-19 of 30 Crore people in the next few months.

Export of Pharmaceuticals products from India stood at US$ 16.8 billion in FY 2020 and US$ 2.07 billion in the month of October 2020. In the first 3 quarters of FY 2021, India exported pharmaceuticals worth US$ 15.86 billion. India supplied around 45 tons and 400 million tablets of hydroxychloroquine to around 114 countries globally to treat the covid patients in the initial stage of the covid-19 pandemic. Exports in FY 2021 of Indian pharma products are expected to cross US$ 24 billion, increasing by over 16% when compared to FY 2020.

After the onset of COVID 19, the Indian pharmaceutical sector became the busiest sector in the Indian economy. The pandemic proved to be a boon in disguise for the Indian pharmaceutical sector. 

 

 

FAQS ON WINTAC LTD DELISTED STOCK 

 

Q1) In which sector does Wintac Limited operate?

Wintac Limited operates in the Pharma sector.

 

Q2) Who is the principal promoter of Wintac Limited?

Veego Pharma is the principal promoter of Wintac Limited.

 

Q3) From where i can find the Wintac share price?

You can easily find Wintac share price on wwipl.com or contact us 

 

Q4) What is the scrip name of Wintac Limited?

WINTAC 

 

Q5) Is Wintac limited share buying worth it?

With the growth of the pharmaceutical sector in India, there is a huge amount of growth prospects for Wintac Limited as well. 

Annual Report

Wintac Annual Report 2020-21

Download

Wintac Annual Report 2019-20

Download
Wealth Wisdom - WWIPL
Support Megha Support Neha

News Alert